Helius Medical Technologies (HSDT) Expected to Announce Quarterly Earnings on Wednesday

Helius Medical Technologies (NASDAQ:HSDT) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.94) per share and revenue of $0.10 million for the quarter.

Helius Medical Technologies Stock Down 0.9 %

Shares of Helius Medical Technologies stock opened at $0.40 on Wednesday. The business’s fifty day simple moving average is $0.59 and its 200-day simple moving average is $0.61. Helius Medical Technologies has a 52 week low of $0.37 and a 52 week high of $7.19. The firm has a market cap of $1.48 million, a PE ratio of -0.06 and a beta of 1.62.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.